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ABSTRACT
Background: The placement of percutaneous endo-
scopic gastrostomy tubes is a common procedure in pa-
tients with head and neck cancer who require adequate
nutrition because of the inability to swallow before or
after surgery and adjuvant therapies. A potential compli-
cation of percutaneous endoscopic gastrostomy tubes is
the metastatic spread from the original head and neck
tumor to the gastrostomy site.
Methods: This is a case of a 59-year-old male with a
(T4N2M0) Stage IV squamous cell carcinoma of the oro-
pharynx who underwent percutaneous endoscopic gas-
trostomy tube placement at the time of his surgery and
shortly thereafter developed metastatic spread to the gas-
trostomy site. A review of the published literature regard-
ing the subject will be made.
Results: Twenty-nine cases of percutaneous endoscopic
gastrostomy site metastasis occurring in patients with
head and neck cancer have been previously reported in
the literature. The pull-through method of gastrostomy
tube placement had been used in our patient as well as in
the majority of the other cases reviewed in the literature.
Conclusion: The metastatic spread of head and neck
cancer to the percutaneous endoscopic gastrostomy site is
a very rare occurrence. The direct implantation of tumor
through instrumentation is the most likely explanation for
metastasis; however, hematogenous seeding is also a pos-
sibility. To prevent this rare complication, other tech-
niques of tube insertion need to be considered.
Key Words: Head and neck cancer, Percutaneous endo-
scopic gastrostomy.
INTRODUCTION
Gauderer et al1 first described the technique of percuta-
neous endoscopic gastrostomy (PEG) in 1980. It was orig-
inally introduced as an alternative method to conventional
open surgical gastrostomy for nutritional support in pa-
tients with head and neck cancer. It is considered to be a
safer procedure, with a lower complication rate, is less
invasive, generally well tolerated, and more cost effec-
tive.2 Percutaneous endoscopic gastrostomy has been
shown to improve nutritional status and the quality of life
in these patients.3–5
Complications of percutaneous endoscopic gastrostomy
are relatively uncommon, but include local infection,
hemorrhage, dislodgment, peritonitis, bowel perforation,
and aspiration pneumonia.6 Another rare complication
that appears to be becoming more prevalent is the meta-
static implantation of tumor at the PEG tube site. The first
case of gastric and abdominal wall metastasis secondary
to PEG placement in a patient with head and neck cancer
was reported in 1989.7 Since then, 29 similar cases of
tumor implantation at the PEG site have been reported.
We report another case of tumor implantation at the PEG
site from squamous cell cancer (SCC) of the head and
neck. A review of the literature helped to determine the
possible mechanism of spread.
CASE REPORT
The patient is a 59-year-old male with a history of alco-
holism and tobacco abuse. In March 2004, he was diag-
nosed with a (T4N2M0) Stage IV squamous cell carcinoma
(SCC) of the right soft palate, tonsilllar fossa, retromolar
trigone, and base of the tongue. He underwent wide
resection that included half of the soft palate, the tonsillar
region, the retromolar trigone, and about 40% of the base
of the tongue. He also underwent a modified neck dis-
section. To cover the defect, a skin/subcutaneous free flap
from the abdomen was utilized. A tracheostomy and PEG
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CASE REPORTtube placement were performed at the time of the original
surgery. Postoperatively, the patient had problems with
delirium tremens but was able to be discharged on day 7
tolerating tube feedings. All surgical margins were free of
tumor involvement. The patient had 2 positive nodes in
the right neck, 1 with extracapsular spread, and both
lymphovascular and perineural invasion had occurred
within the specimen. The patient subsequently underwent
34 treatments of radiation therapy (XRT).
In April 2004, the patient also underwent mandibular
odontectomy, alveolectomy, and minor revision of the
free flap at the alveolar process. Close to 1 month after
insertion of the PEG tube, the patient stated he noticed
some granulation tissue forming around the tube site. This
progressed rapidly, but the patient neglected to seek med-
ical attention. In July 2004, the patient was referred by his
family practitioner with a large 4-cm fungating mass
around his tube site. Within 3 weeks, the mass reached a
size of 9 cm in diameter (Figure 1). An incisional biopsy
was obtained that revealed SCC, and it was felt that this
came from the patient’s original head and neck cancer.
Upper endoscopy was performed that showed the tumor
around the bumper or mushroom within the stomach
(Figure 2). Further evaluation by computed tomography
(CT) showed a large mass extending through the abdom-
inal wall (Figure 3). Metastatic workup to include CT of
the head, neck, chest, and abdomen were negative, ex-
cept for the mass in the abdominal wall and stomach.
Radiation-oncology consultation was obtained, and the
patient subsequently received 4500 rads, 25 fractions to
the abdominal wall. A significant reduction in the size of
the mass was obtained. Several weeks later following
radiation therapy, the patient had a CT scan that did not
show any residual disease. An en bloc resection of the
abdominal wall around the PEG to include a wedge re-
section of the stomach was performed. Margins were
clear, and no residual tumor was detected. The abdominal
wall was repaired with Dual Mesh. The patient was dis-
charged 5 days later tolerating a soft puree diet. The
patient did well initially; on follow-up, however, exactly 1
year later, from the time of the patient’s original head and
Figure 1. Large exophytic lesion around the percutaneous en-
doscopic gastrostomy tube.
Figure 2. Endoscopically visible tumor around the percutaneous
endoscopic gastrostomy tube bumper.
Figure 3. Computed tomographic scan of the abdomen reveal-
ing transabdominal extent of the tumor.
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The patient is presently in hospice care.
DISCUSSION
Since its introduction in 1980, PEG has become increas-
ingly popular after surgery, and radiotherapy for improv-
ing patient’s nutritional status and reducing the duration
of the hospital stay.1 It is also the preferred method for
feeding patients with severe facial trauma and dysphagia
as a result of advanced neurological disease and more
recently has been used successfully in patients who re-
quire prolonged gastrointestinal decompression.2 Surgical
or open gastrostomy has the disadvantage of requiring a
laparotomy, and most studies have shown it to be associ-
ated with more complications than PEG.8,9
Several methods have been described for the percutane-
ous endoscopic insertion of the gastrostomy tube, of
which the Ponski-Gauderer pull method is the most
widely used.1 The pull-through method involves passing
the endoscope through the mouth into the stomach. An
angiocatheter is introduced through the abdominal wall
into the insufflated stomach under direct visualization. A
wire is then passed through the angiocatheter, snared
endoscopically, and pulled through the patient’s mouth.
The gastrostomy tube is then attached to the end of the
wire and pulled back through the mouth and esophagus
into the stomach and out through the abdominal wall.
Another less popular technique, known as the “push-
through” or “introducer” technique uses the Seldinger
method to directly place the tube through the abdominal
wall into the stomach that has been insufflated by way of
the esophagus.10 This technique does not require passage
of the gastrostomy tube over the pharynx.
The reported complication rate for PEG is about 5% com-
pared with about 10% for open gastrostomy, and the
reported procedure-related mortality rate is less than 1%
compared with about 4% for open gastrostomy.8,9 Com-
plications of PEG include aspiration pneumonia and air-
way compromise, hemorrhage, tube dislodgement, ab-
dominal wall infection, intraperitoneal leakage and
peritonitis, gastroesophageal reflux, dyspnea, transient
pneumoperitoneum, tube blockage, pain and infection
around the tube site, and formation of granulation tissue.2
A rare but increasingly reported complication in patients
with head and neck cancer is the metastatic spread of SCC
to the PEG tube site.
The reported incidence of metastatic neoplasms to the
stomach have been 0.7% to 2%.11–13 In autopsy findings by
Antler et al,14 the incidence of lung cancer metastasizing to
the stomach was as high as 9%.
The spread of cancer to a gastrostomy stoma was first
reported in 1971 by Alagaratnam,15 who performed the
procedure in an open manner. Since 1989, 29 cases have
been reported of metastatic seeding from the upper aero-
digestive tract to the PEG site. A total of 29 of these
patients including our patient had squamous cell carci-
noma and 1 had adenocarcinoma (Table 1).2,7,15–39
It appears that the pull method was used in all these cases.
In our case, the patient described tumor developing
around the PEG tube 1 month after insertion, but the
mean time to PEG site implantation in previously reported
cases was 8 months (range, 2 to 17). It is also interesting
to note that almost all cases involved advanced (Stage III,
IV) SCC of the head and neck region. The exception to
that is an adenocarcinoma of the distal esophagus.16
Various theories exist concerning the mechanism of
spread of the tumor to the PEG site, which include the
direct implantation at the time of PEG placement, hema-
togenous or lymphatic spread, and the possibility of shed-
ding of tumor cells into the gastrointestinal tract from the
original head and neck cancer. No controlled experiments
have been done to determine whether a particular PEG
technique or simply the trauma secondary to the gastros-
tomy is responsible.24
One hypothesis is that the pull method that was used in all
reportable cases may implant or seed malignant cells
along the path where instruments have injured the tissue.
Tumor cells from the oropharynx coat and contaminate
the bumper of the PEG tube as it is pulled through. This
theory is also supported by cases reported by Sharma et
al18 and Potochny et al,19 as well as others (Table 1).20–23,27
In an effort to clarify the mechanism of spread, Douglas et al
used a tumor kinetic model and concluded that direct im-
plantation of cells is more likely than hematogenous spread
in patients whose metastasis appears within 12 months of
PEG placement.25,26 In a review of cases since 1989, it was
noted that a substantial proportion of patients had PEG
metastasis develop at a very short interval after the proce-
dure, as early as 2 months.25 Our patient noticed the tumor
within 1 month but failed to seek medical attention.
A study by Kodama et al40 reported that surgical stress might
cause an increase in tumor metastasis because high levels of
serum cortisol after a surgical procedure may induce mor-
phological changes, both in the capillary lumen and on the
tumor cell surface, that may facilitate retention of tumor cells.
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implantation causes tumor metastasis.28
Another theory is that metastasis at the gastrostomy stomata
is related to either hematogenous or lymphatic spread of
tumor cells.17,26,29,41,42 This hypothesis is in agreement with
accepted ideas regarding the mechanism of cancer metasta-
sis.43 In the majority of cases, the primary tumor had known
lymph node invasion (before gastrostomy tube placement),
and in over half the cases, distant metastases were discov-
ered previously or concurrently with the stomal metastasis.17
This implies that tumor cells were circulating in the lym-
phatic channels and blood stream.
Table 1.
Cases of Metastasis to Gastrostomy Site
Reference Cancer Histology
and Stage
Primary Tumor
Location
Insertion
Method
Metastasis Interval
(mos.)
Concurrent
Metastasis
1977 Alagaratnam
15 SCC, 4 Oropharynx, Larynx Open 24 None
1989 Preyer
7 SCC, 4 Nasopharynx Pull 3 Lungs
1991 Bushnell
30 SCC, 4 Larynx, Lungs Pull 15 Skin
1992 Huang
31 SCC, 4 Oropharynx, Larynx Pull 6 Not reported
1993 Heinbokel
16 Adenoca, 4 Gastric cardia esophagus Pull 2 Not reported
1993 Laccourreye
20 SCC, 4 Hypopharynx Pull 11 Liver
1993 Massoun
32 SCC, 4 Oropharynx Pull 4 Lungs
1993 Meurer
29 SCC, 4 Oropharynx, Larynx Pull 12 Lungs
1993 Meurer
29 SCC, 4 Oropharynx Pull 15 Lungs
1994 Schiano
33 SCC, 4 Hypopharynx Pull 4 Not reported
1994 Sharma
18 SCC, 4 Oropharynx Pull 6 None
1995 Becker
34 SCC, 4 Hypopharynx Pull 3 Lungs
1995 Becker
34 SCC, 3 Cervical Esophagus Pull 5 Local relapse
1995 Lee
27 SCC, 4 Oropharynx Pull 13 Gastric ligaments
1998 Van-Erpecum
21 SCC, 4 Hypopharynx Pull 2–10 None
1995 Wilson
35 SCC, 4 Hypopharynx Pull Not reported Not reported
1997 Schneider
22 SCC, 4 Oropharynx Pull 10 None
1997 Thorburn
23 SCC, 4 Hypopharynx, Larynx Pull 11 Not reported
1998 Potochny
19 SCC, 4 Hypopharynx Pull 9 None
1999 Deinzer
36 SCC, 3 Proximal Esophagus Pull 3 Not reported
1999 Hosseini
37 SCC, 2/3 Distal Esophagus Pull 2 None
2000 Brownl
7 SCC, 3 Mid Esophagus Pull 9 Lungs, spine
2000 Peghini
38 SCC, 4 Tongue Pull 9 Skin, Colon, Bone
2000 Douglas
25 SCC, 4 Tonsillar Fossa Pull 3.6 None
1996 Lauvin
39 SCC, 4 Esophagus Pull 4 Not reported
2001 Sinclair
28 SCC, 3 Tongue Pull 5 Axillary Nodes
2001 Cossentino
26 SCC, 4 Tongue Pull 8 Lung
2001 Cossentino
26 SCC, 2 Tongue Pull 9 None
2002 Anath
2 SCC, 4 Floor of mouth Pull 3 None
2003 Thakore
24 SCC, 4 Larynx Pull Unable to determine Lungs, Bone, Skin, Brain
2005 Mincheff SCC, 4 Oropharynx Pull 1 None
*SCC  small cell carcinoma.
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The exact mechanism of gastric and abdominal wall me-
tastasis in patients with PEG placement still remains un-
clear and controversial. Since 1989, almost every year a
case of metastatic implantation at the PEG tube site for
head and neck cancer has been reported. PEG placement
by the pull method appears to remain the preferred or
standard procedure for patients with head and neck can-
cer in spite of the overwhelming evidence not to use this
method. Special precautions must be taken during the
procedure to minimize the disruption of tumor cells. It is
our suggestion that an alternative to the pull method
should be considered in this select group of patients.
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